AstraZeneca PLC
AZNHealthcare
£150.78+0.37%
Key Metrics
Market Cap
£233.8B
P/E Ratio
30.5
P/B Ratio
636.3
Div Yield
1.6%
EPS
£0.0
Profit Margin
17.4%
Beta
0.2
52w Range
£95.74 – £157.32
About AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze,
Sector Peers (Healthcare)
Data sourced from Yahoo Finance. Prices in GBP. Updated at build time. This is not financial advice — see our disclaimer.